Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models.
Neurobiol Dis
; 124: 276-288, 2019 04.
Article
in En
| MEDLINE
| ID: mdl-30381260
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinsonian Disorders
/
Alpha-Synuclein
/
Antibodies, Monoclonal
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Neurobiol Dis
Journal subject:
NEUROLOGIA
Year:
2019
Type:
Article